3 Top Growth Stocks to Buy in the First Half of 2026 [Yahoo! Finance]
Mirum Pharmaceuticals, Inc. - common stock (MIRM)
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Mirum Pharmaceuticals could have multiple catalysts in 2026. 10 stocks we like better than Mirum Pharmaceuticals › The new year isn't looking so new now. January is already nearly halfway over. Before you know it, we'll be looking ahead to 2027. No one can slow down the hands of time. It's important to seize great opportunities as soon as possible. That's why I believe the following three top growth stocks are excellent choices to consider buying in the first half of 2026. I really like the growth prospects Meta Platforms (NASDAQ: META) has with its Meta Ray-Ban Display glasses. They're the first artificial intelligence (AI) glasses with a private in-lens display and a neural band wrist control. I view Meta's first-mover advantage as a big plus. Is Meta CEO Mark Zuckerberg correct that glasses are "the ideal form factor for AI"? Yep. No other device can process everything a user sees and hears. It isn't surprising to me in the least that Meta is selling so many of its glass
Show less
Read more
Impact Snapshot
Event Time:
MIRM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MIRM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MIRM alerts
High impacting Mirum Pharmaceuticals, Inc. - common stock news events
Weekly update
A roundup of the hottest topics
MIRM
News
- Mirum Pharmaceuticals (NASDAQ:MIRM) had its "buy" rating reaffirmed by analysts at HC Wainwright.MarketBeat
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Mirum Pharmaceuticals (NASDAQ:MIRM) had its "buy" rating reaffirmed by analysts at Cowen Inc.MarketBeat
- Mirum Director Sells $400K Amid 91% Stock Surge -- Here's What the Firm Expects for 2026 [Yahoo! Finance]Yahoo! Finance
MIRM
Earnings
- 11/4/25 - Beat
MIRM
Sec Filings
- 1/16/26 - Form 4
- 1/15/26 - Form 144
- 1/12/26 - Form 8-K
- MIRM's page on the SEC website